Abivax SA's market cap is currently €467.07M. The company's EPS TTM is €-3.281; its P/E ratio is ―; Abivax SA is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is €-0.68. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 4.62M	€ 4.58M	€ 37.00K	€ 14.00K	€ -7.00K
Gross Profit	€ 4.49M	€ 4.51M	€ -119.00K	€ -52.00K	€ -87.00K
Operating Income	€ -127.38M	€ -56.65M	€ -52.19M	€ -39.59M	€ -33.27M
EBITDA	€ -133.21M	€ -53.31M	€ -42.20M	€ -39.53M	€ -33.22M
Net Income	€ -147.74M	€ -69.85M	€ -41.36M	€ -37.55M	€ -30.63M
Balance Sheet
Cash & Short-Term Investments	€ 260.99M	€ 26.95M	€ 60.70M	€ 29.30M	€ 9.77M
Total Assets	€ 327.06M	€ 73.35M	€ 110.36M	€ 71.30M	€ 51.73M
Total Debt	€ 55.46M	€ 46.72M	€ 53.45M	€ 33.98M	€ 20.74M
Net Debt	€ -196.48M	€ 19.78M	€ -7.25M	€ 4.69M	€ 10.98M
Total Liabilities	€ 131.05M	€ 71.47M	€ 81.59M	€ 66.63M	€ 39.95M
Stockholders' Equity	€ 196.01M	€ 1.88M	€ 28.77M	€ 4.67M	€ 11.78M
Cash Flow
Free Cash Flow	€ -97.39M	€ -69.55M	€ -47.30M	€ -30.72M	€ -28.41M
Operating Cash Flow	€ -97.13M	€ -65.58M	€ -45.66M	€ -29.82M	€ -27.47M
Investing Cash Flow	€ -8.10M	€ -3.73M	€ -1.46M	€ -575.00K	€ -370.00K
Financing Cash Flow	€ 335.29M	€ 35.56M	€ 78.51M	€ 49.93M	€ 24.61M

Currency in EUR

Abivax SA Earnings and Revenue History

Income Statement >

Abivax SA Debt to Assets

Balance Sheet >

Abivax SA Cash Flow

Cash Flow >

Abivax SA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing